tiprankstipranks
Trending News
More News >
Livzon Pharmaceutical Group Class H (HK:1513)
OTHER OTC:1513
Hong Kong Market

Livzon Pharmaceutical Group (1513) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

1513 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Livzon
Pharmaceutical Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1513 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:1513 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1513 Financial Forecast

1513 Earnings Forecast

Next quarter’s earnings estimate for 1513 is HK$0.47 with a range of HK$0.47 to HK$0.47. The previous quarter’s EPS was HK$0.58. 1513 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 1513 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1513 is HK$0.47 with a range of HK$0.47 to HK$0.47. The previous quarter’s EPS was HK$0.58. 1513 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 1513 has Performed in-line its overall industry.

1513 Sales Forecast

Next quarter’s sales forecast for 1513 is HK$3.06B with a range of HK$3.06B to HK$3.06B. The previous quarter’s sales results were HK$3.11B. 1513 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 1513 has Performed in-line its overall industry.
Next quarter’s sales forecast for 1513 is HK$3.06B with a range of HK$3.06B to HK$3.06B. The previous quarter’s sales results were HK$3.11B. 1513 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 1513 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
HSBC
HK$37.23
Sell
20.33%
Upside
Reiterated
09/30/25
Citi
HK$34HK$48
Buy
55.14%
Upside
Reiterated
08/26/25
Citi Sticks to Its Buy Rating for Livzon Pharmaceutical Group (LVZPF)
Goldman Sachs Analyst forecast on HK:1513
Goldman Sachs
Goldman Sachs
HK$23.22HK$26.02
Hold
-15.90%
Downside
Reiterated
08/22/25
Goldman Sachs Sticks to Their Hold Rating for Livzon Pharmaceutical Group (LVZPF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
HSBC
HK$37.23
Sell
20.33%
Upside
Reiterated
09/30/25
Citi
HK$34HK$48
Buy
55.14%
Upside
Reiterated
08/26/25
Citi Sticks to Its Buy Rating for Livzon Pharmaceutical Group (LVZPF)
Goldman Sachs Analyst forecast on HK:1513
Goldman Sachs
Goldman Sachs
HK$23.22HK$26.02
Hold
-15.90%
Downside
Reiterated
08/22/25
Goldman Sachs Sticks to Their Hold Rating for Livzon Pharmaceutical Group (LVZPF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Livzon Pharmaceutical Group

3 Months
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+1.90%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.90% per trade.
1 Year
Success Rate
1/2 ratings generated profit
50%
Average Return
+5.55%
reiterated a sell rating 3 months ago
Copying Linda Shu's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.55% per trade.
2 Years
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+41.50%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +41.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1513 Analyst Recommendation Trends

Rating
Apr 25
Jun 25
Aug 25
Sep 25
Dec 25
Strong Buy
1
0
1
1
2
Buy
3
3
3
0
0
Hold
1
2
3
2
1
Sell
2
2
0
1
1
Strong Sell
0
0
0
0
0
total
7
7
7
4
4
In the current month, 1513 has received 2 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. 1513 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

1513 Stock Forecast FAQ

What is HK:1513’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1513’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1513, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Livzon Pharmaceutical Group Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is Livzon Pharmaceutical Group Class H’s share price target?
      Currently, no data Available
      What do analysts say about Livzon Pharmaceutical Group Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Livzon Pharmaceutical Group Class H?
      To buy shares of HK:1513, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.